Foresite Capital Management IV as of March 31, 2019
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 16 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed (INSM) | 16.0 | $45M | 1.5M | 29.07 | |
| Cymabay Therapeutics | 12.6 | $35M | 2.6M | 13.28 | |
| Ascendis Pharma A S (ASND) | 10.4 | $29M | 245k | 117.70 | |
| Biohaven Pharmaceutical Holding | 9.6 | $27M | 519k | 51.47 | |
| Optinose (OPTN) | 9.0 | $25M | 2.4M | 10.30 | |
| Immunomedics | 8.0 | $22M | 1.2M | 19.21 | |
| Myokardia | 7.2 | $20M | 385k | 51.99 | |
| Replimune Group (REPL) | 6.7 | $19M | 1.2M | 15.22 | |
| Cytokinetics (CYTK) | 5.0 | $14M | 1.7M | 8.09 | |
| Rhythm Pharmaceuticals (RYTM) | 4.0 | $11M | 405k | 27.41 | |
| Alector (ALEC) | 3.8 | $11M | 1.2M | 8.87 | |
| Aerie Pharmaceuticals | 3.6 | $10M | 212k | 47.50 | |
| Si-bone (SIBN) | 1.4 | $3.9M | 206k | 18.84 | |
| Voyager Therapeutics (VYGR) | 1.2 | $3.4M | 178k | 19.14 | |
| Arbutus Biopharma (ABUS) | 1.0 | $2.9M | 804k | 3.58 | |
| Kiniksa Pharmaceuticals | 0.4 | $1.2M | 64k | 18.05 |
